History
Beacon Sciences, LLC, was founded in 2007 based on pioneering work by Dr. Eric V. Anslyn, of The University of Texas, to deliver visible and simple custom assays to the scientific community using the power of chemiluminescence. Our proprietary technology empowers the environmental, life sciences, clinical diagnostics and biodefense industries to retrieve data and results quickly and cost-effectively without the need for heavy and expensive bench-top equipment.
Management
Beacon Sciences, LLC, is an Emergent Technologies Inc. (ETI) portfolio company and ETI provides all management services and operations support.
About Emergent Technologies, Inc.
Headquartered in Austin, Texas, Emergent Technologies, Inc. (ETI) is a life sciences technology investment and management company which provides early stage funding and development for scientific discoveries originating at universities and research institutions. The Company creates value by transforming scientific breakthroughs into technology platforms with multiple applications. ETI's unique innovation process enables the Company to select promising scientific discoveries for development, maximize the value of intellectual property and manage both cost and risk associated with the commercial development of early stage technologies. ETI is dedicated to turning research into revenue and, in the process, introducing compelling solutions to meet important market needs. For more information, visit the company website www.etibio.com
Press
September 8, 2008 :
Beacon Sciences Announces New Color-Changing Assay for Creatinine 
April 10, 2007 :
The University of Texas at Austin Licenses Molecular Recognition
Assay Technology to Beacon Sciences, LLC
To request more information or to contact a representative, please email press@beaconsciences.com
